Skip to main content
padlock icon - secure page this page is secure

Pre or posttreatment with ethanol and ethyl pyruvate results in distinct antiinflammatory responses of human lung epithelial cells triggered by interleukin6

Buy Article:

$42.00 + tax (Refund Policy)

Increased local and systemic levels of interleukin (IL)6 are associated with inflammatory processes, including neutrophil infiltration of the alveolar space, resulting in lung injury. Our previous study demonstrated the beneficial antiinflammatory effects of acute exposure to ethanol (EtOH) in an acute in vivo model of inflammation. However, due to its sideeffects, EtOH is not used clinically. In the present study, the effects of EtOH and ethyl pyruvate (EtP) as an alternative antiinflammatory drug prior to and following application of an IL6 stimulus on cultured A549 lung epithelial cells were compared, and it was hypothesized that treatment with EtOH and EtP reduces the inflammatory potential of the A549 cells. Time and dosedependent release of IL8 from the A549 cells was observed following stimulation with IL6. The release of IL8 from the A549 cells was assessed following treatment with EtP (2.510 mM), sodium pyruvate (NaP; 10  mM) or EtOH (85170  mM) for 1, 24 or  72 h, prior to and following IL6 stimulation. The adhesion capacities of neutrophils to the treated A549 cells, and the expression levels of cluster of differentiation (CD)54 by the epithelial cells were measured. Treatment of the A549 cells with either EtOH or EtP significantly reduced the IL6induced release of IL8. This effect was observed in the pre and poststimulatory conditions, which is of therapeutic importance. Similar data was revealed regarding the IL6induced neutrophil adhesion to the treated A549 cells, in which pre and posttreatment with EtOH or EtP decreased the adhesion capacity, however, the results were dependent on the duration of incubation. Incubation durations of 1 and 24 h decreased the adhesion rates of neutrophils to the stimulated A549 cells, however, the reduction was only significant at 72 h posttreatment. The expression of CD54 was reduced only following treatment for 24 h with either EtOH or EtP, prior to IL6 stimulation. Therefore, EtOH and EtP reduced the inflammatory response of lung epithelial cells, and the potential of EtP to mimic EtOH was observed in the pre and posttreatment conditions.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Department of Trauma, Hand and Reconstructive Surgery, University Hospital, Goethe University, Frankfurt am Main D60590, Germany 2: Department of Trauma Surgery, Trauma Center Murnau, Murnau D82418, Germany 3: Department of General Surgery, University Hospital, Goethe University, Frankfurt am Main D60590, Germany

Publication date: August 1, 2015

More about this publication?
  • Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more